absorb everyday moments

#1 Perscribed Pert.

For patients with Exocrine Pancreatic Insufficiency (EPI) due to cystic fibrosis, chronic pancreatitis, pancreatectomy, or other conditions

Learn More About CREON

Getting Started With

36K capsules can be an appropriate strength for
many patients.1

See CREON Dosing Overview

CREON 36,000 may not be appropriate for all patients. CREON is also available in 3,000,
6,000, 12,000, and 24,000 lipase unit capsules.1
Capsules shown are not actual size and do not represent exact color shade. For illustrative purposes only. The active ingredient in CREON evaluated in clinical trials is lipase.
Example per-meal starting dose for a patient who weighs ≥160 lb to 315 lb.1

Register for Upcoming
Educational Presentations

Please join us for an AbbVie educational presentation about
CREON and EPI. Register today to reserve your space.

CREON & EPI due to chronic
pancreatitis, pancreatectomy,
or other conditions:

View Events

CREON & EPI due to
cystic fibrosis:

View Events

Communication icons

Optimized Resources for Your
Next Patient Appointment

Elevate your next in-person or telemedicine appointment
with downloadable resources for before, during, and
after your calls

Get Started

Patient Support Programs

Eligible CREON patients pay as little as $5 (or less) per month for their CREON prescription.*

View Complete
Program Details
CREON® copay savings card.

*Eligibility: Available to patients with commercial prescription insurance coverage for CREON who meet eligibility criteria. Copay assistance, vitamins and nutritional supplements, if any, are not available to patients receiving prescription reimbursement under any federal, state, or government-funded insurance programs (for example, Medicare [including Part D], Medicare Advantage, Medigap, Medicaid, TRICARE, Department of Defense, or Veterans Affairs programs) or where prohibited by law. Offer subject to change or discontinuance without notice. Restrictions, including monthly maximums, may apply. This is not health insurance.